Avibactam/ceftazidimeAcquired drug resistance: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2051卷 / 1期

关键词：

D O I：

10.1007/s40278-025-79571-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：51 / 51

相关论文

共 50 条

[41] Crizotinib/lorlatinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2022, 1922 (1) : 202 - 202
[42] Avibactam/ceftazidimeAcute kidney injury: 2 case reports
Reactions Weekly, 2019, 1747 (1) : 59 - 59
[43] Avibactam/ceftazidimeGastrointestinal intolerance and neutropenia: 2 case reports
Reactions Weekly, 2020, 1797 (1) : 50 - 50
[44] Avibactam/ceftazidime/imipenemEncephalopathy and neurologic symptoms: 2 case reports
Reactions Weekly, 2022, 1937 (1) : 102 - 102
[45] Afatinib/erlotinib/gefitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2018, 1696 (1) : 18 - 18
[46] Erlotinib/gefitinib/osimertinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2021, 1856 (1) : 201 - 201
[47] Dupilumab/upadacitinibTreatment failure and drug resistance: 2 case reports
Reactions Weekly, 2024, 2026 (1) : 121 - 121
[48] AntineoplasticsAcquired drug resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1903 (1) : 46 - 46
[49] AntiretroviralsAcquired drug resistance and virological failure: 2 case reports
Reactions Weekly, 2025, 2042 (1) : 55 - 55
[50] ImatinibAcquired drug resistance and treatment failure: 2 case reports
Reactions Weekly, 2025, 2040 (1) : 445 - 445

← 1 2 3 4 5 →